Long-Term Outcomes Following Behavioral Weight Management Programs: Worth the Weight
- PMID: 36974899
- PMCID: PMC10487370
- DOI: 10.1161/CIRCOUTCOMES.123.009965
Long-Term Outcomes Following Behavioral Weight Management Programs: Worth the Weight
Keywords: Editorials; adult; obesity; prevalence; weight loss.
Conflict of interest statement
Dr Pagidipati reports the following: Institutional research support from Boehringer Ingelheim & Eli Lilly. Research support from Amgen, Boehringer Ingelheim, Eggland’s Best, Eli Lilly, Novartis, Novo Nordisk, Verily Life Sciences; Consultation/Advisory Panels for Boehringer Ingelheim, Eli Lilly, AstraZeneca, Novartis, Merck, CRISPR Therapeutics, and Novo Nordisk. Executive Committee member for trials sponsored by Novo Nordisk and by Amgen.
Comment on
-
Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis.Circ Cardiovasc Qual Outcomes. 2023 Apr;16(4):e009348. doi: 10.1161/CIRCOUTCOMES.122.009348. Epub 2023 Mar 28. Circ Cardiovasc Qual Outcomes. 2023. PMID: 36974678 Free PMC article.
References
-
- Adult Obesity Facts. https://www.cdc.gov/obesity/data/adult.html. Accessed March 09, 2023.
-
- Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, Long MW, Gortmaker SL. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381:2440–2450. doi: 10.1056/NEJMsa1909301 - PubMed
-
- Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Jr, Grossman DC, Kemper AR, et al. ; US Preventive Services Task Force. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US preventive services task force recommendation statement. JAMA. 2018;320:1163–1171. doi: 10.1001/jama.2018.13022 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
